Most stem cell suppliers solve one of those problems. ATOM solves all three. Premium umbilical cord MSCs with verified protocols, the patient acquisition system that fills your schedule, and direct-from-lab pricing that protects your margin.
That's the obligation. To the cells, to the clinicians, to the patients receiving them.
Wharton's Jelly umbilical cord MSCs from an FDA registered tissue lab. Every lot independently tested before release. Eurofins-verified sterility. Ohio University-verified potency. Certificate of Analysis on every shipment.
Lab-Tested · COA Per Lot · Third-Party VerifiedYou can't deliver stem cells to patients who don't walk through the door. We run the same patient acquisition system at your clinic that took our flagship from zero to 64 procedures in month three — Google, Meta, follow-up, close.
$1.18M Pipeline · 12.36% Close · 25/Mo TargetDirect-from-lab pricing. No broker layer. No surprise fees. Partners hold 73–80% margins on every procedure. At the 25/month target that's roughly $68K monthly take-home — and our flagship is doing more than double that.
73–80% Margin · $68K/Mo Target · Transparent Pricing
Every vial of ATOM goes through independent testing and release review before it ships. Most suppliers ship without ever showing you the data. We refuse to. Process integrity isn't a marketing claim — it's the difference between a vial of cells and a vial of mostly debris.
Before we asked a single clinic to trust ATOM, we built the product standard first. Every batch is independently tested. Every cell is ethically sourced. Every vial ships with the documentation your compliance officer will ask for.
Mesenchymal stem cells from consenting mothers at scheduled delivery. No harm to mother or newborn. No embryonic tissue. Every donor screened.
AATB & AABB CompliantEvery batch independently sterility-tested by Eurofins DPT. Results ship with every order. Not our lab. Theirs.
Eurofins DPT · CLIA 06D0717586Cell viability and particle analysis verified by Ohio University Innovation Center. Real third-party data, real lab reports.
Ohio University Innovation CtrTissue processed in full federal compliance. Every batch documented. Every vial traceable. Chain of custody end to end.
FEI 3027285830Wharton's Jelly umbilical cord MSCs from an FDA registered tissue lab. Every lot independently tested. COA on every shipment. Free exosomes included with every cell vial.
The actual patient acquisition funnel running at our flagship. Every stage. Every conversion percentage. Nothing rounded, nothing hidden. When you sign as an ATOM partner, this exact system gets deployed for your clinic.
The Stem Cell Club opened cold. No existing patient base. No brand recognition. Just the ATOM system plugged in and running. What you see here is what a first-year partner can expect.
The partner-level target. Our flagship is already doing more than double this. When the system runs, the math runs with it.
Clear division of labor. Every ATOM partner knows exactly what they own and exactly what we handle.
Place orders through the ATOM partner portal. We ship overnight, cold-chain, with COA. Your job on the product side is inventory — that's it.
We run the proven lead-gen system at your clinic: Google, Meta, direct mail, follow-up sequences, the full funnel. Your schedule fills.
Your team delivers treatment using ATOM-trained protocols. You keep 73–80% margins. You own the patient relationship. You own the profit.
Three educational deep-dives for clinical partners. The science clinicians should be able to defend to every patient who asks.
Exosomes versus stem cells — why the cargo matters more than the cell count, and how 3D culture produces measurably more.
Read Article →Why the shift from 2D flask culture to 3D suspension is producing cells of measurably superior biological relevance.
Read Article →Stress-Selected Enduring Cells — the rare, pluripotent-like subset within every MSC population, and the process to isolate them.
Read Article →Schedule a discovery call. Not a pitch — a conversation about whether your practice is a fit, what your lead flow looks like, and what 25 procedures a month would do for your bottom line.
Currently signing 50 partners · 6 are already inEvery lot is tested before release using industry-standard methodology — an Invitrogen Countess II FL automated counter with trypan blue exclusion, validated against manual hemocytometer counts. Independent sterility testing through Eurofins DPT. Independent potency analysis through Ohio University Innovation Center. Every lot you receive ships with a Certificate of Analysis showing the actual measured results for that specific lot — not a generic spec sheet.
Wharton's Jelly umbilical cord MSCs ethically sourced from consenting mothers at scheduled delivery. All donors undergo rigorous screening for communicable disease before tissue is accepted. Tissues are processed at an FDA registered tissue lab in Florida (FEI 3027285830) in full compliance with AATB and AABB guidelines. Sterility verified by Eurofins DPT (CLIA 06D0717586). Potency verified by Ohio University Innovation Center. COA on every lot.
Two reasons. First — safety. After thaw, cells should be spun down, the cryoprotectant supernatant removed, and the cell pellet resuspended in clean media before injection. Every cryoprotectant manufacturer says do not direct-inject. Using a vial of exosomes as the resuspension medium gives you a clean carrier without adding cost to the patient. Second — biology. Exosomes are the regenerative signaling layer that drives most of what stem cells actually do in the body. Including them as the resuspension medium is biologically additive, not just safer. Free with every cell vial. No markup.
ATOM IV is concentrated Wharton's Jelly for systemic IV delivery — whole-body wellness, longevity, autoimmune support. ATOM Injections include BioScaf scaffolding for sustained localized results — joints, soft tissue, aesthetics. ATOM SSEC™ (formerly MUSE) is our flagship Stress-Selected Enduring Cells — the rare pluripotent-like subset within every MSC population, isolated through our refined production process. Full pricing for all three at atomstemcells.com/products.
Most partners see their first leads within 48 hours of campaigns going live. Onboarding, training, and campaign build typically takes 7–14 days from signed agreement to first patient inquiries. Month 1 is ramp. Month 2 is scale. Month 3 is when the flywheel kicks in — our flagship hit 64 procedures in month three starting cold.
No. The $1,500 is your ad spend — it goes directly into the ad platforms (Google, Meta, direct mail) to generate leads for your clinic. We don't take a cut. It's not a setup fee, software charge, or markup. We run the campaigns because we know what works. You fund them because the patients are yours.
Yes. ATOM is modular. Plenty of clinics want a reliable premium supplier with transparent pricing and nothing else — that's fine. You can start with just the product and add the partner program later. We'll discuss what makes sense for your practice on a discovery call.
25 is the target, not a quota. Our flagship hit 64 in month three starting from zero. The system has been pressure-tested in a real clinic with real patients. If your volume isn't where it should be, we troubleshoot the funnel together — ad spend, close rate, follow-up — until it moves. Partners don't get stranded.
Every order ships overnight with proper cold-chain packaging to maintain product integrity. Delivery is $150 per shipment, nationwide. You receive a Certificate of Analysis with every unit and complete chain-of-custody documentation with every order.